New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
06:10 EDTOCROmnicare upgraded to Buy from Neutral at UBS
UBS upgraded Omnicare due to valuation and said it now believes there is a large generic Namenda XR opportunity in 2016. Price target is $64.
News For OCR From The Last 14 Days
Check below for free stories on OCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
10:04 EDTOCROmnicare discloses whistleblower suit in which DOJ declined to intervene
Subscribe for More Information
07:40 EDTOCROmnicare backs FY14 adjusted EPS view of $3.64-$3.72, consensus $3.69
Subscribe for More Information
07:39 EDTOCROmnicare reports Q2 adjusted EPS 91c, consensus 90c
Reports Q2 revenue $1.61B, consensus $1.59B.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use